Our Blog

Cynata Therapeutics (ASX:CYP) talks stem cell trials & partnerships

26 Oct 2017 – Cynata Therapeutics Limited (ASX:CYP) Managing Director & CEO, Dr. Ross Macdonald provides an update on its Phase 1 clinical trial for the treatment of Graft versus Host Disease (GvHD), its stem cell manufacturing technology and partnerships.

Source: Finance News Network

Share this post